Avid Bioservices Inc (CDMO)

[cjgaddy]

Here’s the 10-21-17 post detailing WCLC’17/Japan (Sunrise subset)

Oct15-18 2017: “WCLC’17 - IASLC’s 18th World Conf. on Lung Cancer”, Yokohama, Japan
Track: Immunology & Immunotherapy, Presentation: Mini-Oral #MA 10
10-17-17 11:30-11:35pm #MA 10.05 (Mini-Oral):
“Improved Outcome for Immune Checkpoint Inhibitors (ICI) in Patients Previously Treated with Bavituximab in the SUNRISE Trial”

FULL info here: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=135586168

= = = = =And then SITC’17 (Sunrise #P87):
Nov8-12 2017: “(SITC) Society for Immunotherapy of Cancer 32nd Annual Meeting”, Natl-Harbor MD
#P87: “Results of Epigenetic-Based Quantitative PCR Assisted Immune Cell Counting Analysis in Bavituximab SUNRISE Trial Subgroup”
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=136007486